N-烯丙去甲间唑新

更新时间:2024-01-10 09:15:55

N-烯丙去甲间唑新结构式
N-烯丙去甲间唑新结构式
委托求购
常用名 N-烯丙去甲间唑新 英文名 n-allylnormetazocine
CAS号 14198-28-8 分子量 257.37100
密度 1.055g/cm3 沸点 373.6ºC at 760mmHg
分子式 C17H23NO 熔点 N/A
MSDS 美版 闪点 169.9ºC
符号 GHS07
GHS07
信号词 Warning

 N-烯丙去甲间唑新名称

中文名 (-)-N-丙烯基去甲变肾上腺素 盐酸盐
英文名 [3H]-(-)-N-Allylnormetazocine
英文别名 更多

 N-烯丙去甲间唑新物理化学性质

密度 1.055g/cm3
沸点 373.6ºC at 760mmHg
分子式 C17H23NO
分子量 257.37100
闪点 169.9ºC
精确质量 257.17800
PSA 23.47000
LogP 3.04030
外观性状 solid | white
蒸汽压 4.11E-06mmHg at 25°C
折射率 1.559
水溶解性 H2O: soluble

 N-烯丙去甲间唑新安全信息

符号 GHS07
GHS07
信号词 Warning
危害声明 H302-H312-H332
警示性声明 P280
危害码 (欧洲) Xn: Harmful;
风险声明 (欧洲) R20/21/22
安全声明 (欧洲) S36
危险品运输编码 NONH for all modes of transport
WGK德国 3

 N-烯丙去甲间唑新文献26

更多文献
Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.

Exp. Eye Res. 107 , 21-31, (2013)

Sigma-1 receptors (σ-1rs) exert neuroprotective effects on retinal ganglion cells (RGCs) both in vivo and in vitro. This receptor has unique properties through its actions on several voltage-gated and...

The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.

Peptides 30 , 2418-2422, (2009)

We previously demonstrated that intracerebroventricular (i.c.v.) administration of the substance P (SP) aminoterminal fragment SP(1-7) attenuates the expression of morphine withdrawal in the male rat....

Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels.

Am. J. Physiol. Cell Physiol. 300(2) , C328-37, (2011)

σ-Receptors are integral membrane proteins that have been implicated in a number of biological functions, many of which involve the modulation of ion channels. A wide range of synthetic ligands activa...

 N-烯丙去甲间唑新英文别名

l-N-Allylnormetazocine
(-)-ANMC
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-,(2R,6R,11R)
(-)-SKF 10.047
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-,(2R-(2alpha,6alpha,11R*))